Convert before you judge
The month 6 result is reported in SI units, 340 µmol/L, while the target is given in conventional units, below 6 mg/dL. The stem gives the conversion: 1 mg/dL = 59.5 µmol/L. Converting: 340 ÷ 59.5 = about 5.7 mg/dL. A serum urate of about 5.7 mg/dL is below the treat-to-target goal of 6 mg/dL, so the target is met and the current dose is continued.
Treat-to-target in gout
Gout is managed with a treat-to-target strategy: the dose of urate-lowering therapy is adjusted until serum urate falls below 6 mg/dL, the level at which monosodium urate crystals dissolve over time. A lower target may be set for clients with tophi. Once the target is reached, the effective dose is maintained long-term, with periodic monitoring. The trend here is good: 8.4 at month 1, 6.3 at month 3 (still above target), and about 5.7 at month 6.
| Time | Value | Converted | Target below 6 mg/dL? |
|---|
| Month 1 | 8.4 mg/dL | — | Not met |
| Month 3 | 6.3 mg/dL | — | Not met |
| Month 6 | 340 µmol/L | about 5.7 mg/dL | Met |
Why the other evaluations are wrong
Option 2 states the target is met but tapers allopurinol off. Urate-lowering therapy is long-term; stopping it lets urate rise again and flares return. Option 3 reads the larger number 340 as being above target without converting it. Option 4 claims the target was met at month 3, but 6.3 mg/dL is above a target of below 6 mg/dL, and lowering the dose now would risk losing control.
Watch out! Unit-switching is a common exam trap. When results appear in different units, convert to the unit of the target before comparing. Large SI numbers are not automatically high.
Nursing role
The nurse checks units on every result, explains to the client that reaching the target is a reason to keep taking the drug rather than to stop, and reinforces lifestyle measures such as limiting alcohol, especially beer, and sugary drinks. Key point! In treat-to-target gout care, once serum urate is below 6 mg/dL the effective dose is continued long-term.